Category Archives: Gene therapy

Authors: Turrell SJ, Macnab SA, Rose A, Melcher AA, Whitehouse A Abstract Herpesvirus saimiri (HVS) is capable of infecting a range of human carcinoma cell types with high efficiency and the viral genome persists as high copy number, circular, non-integrated … Continue reading →

In this study, CaCO(3) delivering pEGFP-C1-p53 could transfect about 5% of the tumor cells in culture. However, the efficiency of tumor cell apoptosis was surprisingly up to 80%. Meanwhile, the results of MTT assay and crystal violet staining showed that … Continue reading →

Molecular imaging is revolutionizing the way we study the inner workings of the human body, diagnose diseases, approach drug design, and assess therapies. The field as a whole is making possible the visualization of complex biochemical processes involved in normal … Continue reading →

Conclusion: These data suggest that rAAV-mediated soluble TRAIL expression under the control of the Tet-On system is a promising strategy for breast cancer therapy. (Source: BMC Cancer)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml

NEW YORK, April 16, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Global Gene Therapy Industry http://www.reportlinker.com/p098244/Global-Gene-Therapy-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=BiologicaThis …Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=gene+therapy&eo=UTF-8

Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml

On antigen binding by the B-cell receptor (BCR), B cells up-regulate protein expression of the key downstream signaling molecule Bruton tyrosine kinase (Btk), but the effects of Btk up-regulation on B-cell function are unknown. Here, we show that transgenic mice … Continue reading →

A popular adage in thinking about disease risk states that “your genes may load the gun, but your environment pulls the trigger.” Nearly a decade following the completion of the Human Genome Project, it is clear that genetic variation is … Continue reading →

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β Cancer Gene Therapy advance online publication, April 20, 2012. doi:10.1038/cgt.2012.14 Authors: S Naik, R Nace, G N Barber & S J Russell (Source: Cancer Gene Therapy) … Continue reading →

Conclusions: These data show that gene therapy, via the direct injection of IDUA-expressing MSCs into the brain, is an effective way to treat neurodegeneration in MPSI mice. (Source: Genetic Vaccines and Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml

This study hints that a gene therapy approach for in-situ reprogramming may provide an alternative for generating new cardiomyocytes within failing hearts. (Source: The EMBO Journal AOP)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml

The recent approval of a new drug and the start of a phase 2 gene therapy trial are creating excitement about future treatment possibilities for people with cystic fibrosis. Zöe Corbyn reports. (Source: LANCET)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml

Human Gene Therapy , Vol. 0, No. 0. (Source: Human Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml

(MedPage Today) — Targeted gene therapy might help stop the spread of melanoma metastases, in this week’s Lab Notes. Also, how can yeast help with depression and a quick fix for cocaine OD. (Source: MedPage Today Cardiovascular) MedWorm Sponsor Message: … Continue reading →